
Outset Medical OM
$ 4.01
4.43%
Annual report 2025
added 02-13-2026
Outset Medical Operating Expenses 2011-2026 | OM
Annual Operating Expenses Outset Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 M | 152 M | 199 M | 179 M | 138 M | 104 M | 52.5 M | 40.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 199 M | 40.4 M | 122 M |
Quarterly Operating Expenses Outset Medical
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.4 M | - | 33.7 M | - | - | - | 40.9 M | - | 33.1 M | 31 M | 30 M | - | 35.6 M | 20.1 M | 16.6 M | - | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.9 M | 13.2 M | 28.2 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abbott Laboratories
ABT
|
14.1 B | $ 102.87 | 0.48 % | $ 179 B | ||
|
Align Technology
ALGN
|
2.19 B | $ 170.6 | -1.23 % | $ 12.8 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 10.83 | -3.82 % | $ 1.63 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
121 M | $ 34.44 | 2.56 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.37 | 2.52 % | $ 265 M | ||
|
Accuray Incorporated
ARAY
|
139 M | $ 0.42 | 6.82 % | $ 43.2 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.58 | 6.52 % | $ 36.1 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 9.63 | 0.94 % | $ 345 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
40.3 M | $ 23.29 | -1.52 % | $ 197 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 36.76 | 1.88 % | $ 5.48 K | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 62.82 | 1.32 % | $ 93 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 81.05 | -0.26 % | $ 47.4 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 34.79 | -2.08 % | $ 1.08 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Aethlon Medical
AEMD
|
9.34 M | $ 2.12 | -1.4 % | $ 3.31 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.03 | 1.43 % | $ 1.63 B | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.86 | 9.41 % | $ 1.13 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.53 | -0.42 % | $ 734 M | ||
|
Inogen
INGN
|
184 M | $ 6.21 | -0.96 % | $ 165 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 54.99 | 2.52 % | $ 1.61 B | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.06 | -1.41 % | $ 377 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.98 | 3.17 % | $ 16.6 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 86.85 | 0.47 % | $ 3.02 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 63.79 | -1.3 % | $ 3.48 B | ||
|
LENSAR
LNSR
|
32.6 M | $ 6.06 | 1.51 % | $ 72.5 M |